![Japan approves drug that cures flu in as soon as 24 hours; Teva repositions brand, shuts offices in US | Radio Compass Blog Japan approves drug that cures flu in as soon as 24 hours; Teva repositions brand, shuts offices in US | Radio Compass Blog](https://www.pharmacompass.com/image/news/banner/Japan-approves-drug-that-cures-flu-in-as-soon-as-24-hours-Teva-repositions-brand-shuts-offices-in-US-1519887670.jpg)
Japan approves drug that cures flu in as soon as 24 hours; Teva repositions brand, shuts offices in US | Radio Compass Blog
Teva Pharmaceutical Industries (NYSE:TEVA) investors are sitting on a loss of 77% if they invested five years ago | Nasdaq
![Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express](https://images.indianexpress.com/2017/07/medicines-l.jpg)
Teva Pharmaceutical: Shares rise after FDA approves new migraine drug | Business News,The Indian Express
![The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen](https://s.yimg.com/ny/api/res/1.2/_o2wIAOHAal7ejUqijQV5A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTQyNw--/https://cdn2.benzinga.com/files/imagecache/600x400xUP/images/story/2012/pulse-trace-163708_1280_3.jpg)